Observational studyBMC ophthalmology2026
Diagnostic capability of ganglion cell complex thickness using spectral domain optical coherence tomography in glaucoma.
Observational study in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study had two main aims: first, aimed to document the normal values of macular ganglion cell complex (GCC) thickness among control eyes and glaucoma suspects and second, to evaluate the diagnostic ability of GCC parameters in distinguishing Primary Open Angle Glaucoma (POAG), Glaucoma Suspects and Controls in a tertiary eye centre in Nepal.
methodsA hospital-based cross-sectional observational study was conducted in Kathmandu, Nepal, from June 2020 to June 2021. GCC parameters (Average GCC, Superior GCC, and Inferior GCC) were measured using spectral-domain Optical Coherence Tomography (OCT). These parameters were compared among groups using Linear Mixed-effect Models, considering considerable inter-eye correlation. Receiver operating characteristic (ROC) curves were constructed, and area under the curve (AUC) values were calculated to assess diagnostic performance.
resultsA total of 203 patients (406 eyes) were included - 76 with POAG, 62 Glaucoma suspects, and 65 Controls. Average GCC, superior GCC and Inferior GCC thickness were 96.54 ± 10.09 μm, 96.68 ± 10.91 μm and 96.43 ± 9.60 μm, in controls; 83.30 ± 11.46 μm, 83.88 ± 12.29 μm, and 81.94 ± 13.19 μm in POAG, and 93.76 ± 7.74 μm, 94.02 ± 8.03 μm, and 93.82 ± 8.27 μm, respectively in glaucoma suspects. All GCC parameters were significantly lower in the POAG group compared with both glaucoma suspects and controls (p < 0.05), even after adjustment for age. The highest diagnostic accuracy was observed for average GCC (AUC = 0.83, 95% C.I. - 0.77-0.92) and inferior GCC (AUC = 0.83, 95% C.I. - 0.76-0.90), both demonstrating excellent discrimination between POAG and controls (AUC = 0.83).
conclusionsAll GCC parameters demonstrated a significant diagnostic capability in detecting POAG, with average GCC and inferior GCC thickness showing the best performance. The single-centre cross-sectional study design, and lack of randomisation were the main limitations of this study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.